Canada markets close in 27 minutes
  • S&P/TSX

    21,176.29
    +89.30 (+0.42%)
     
  • S&P 500

    4,532.52
    +12.89 (+0.29%)
     
  • DOW

    35,580.24
    +122.93 (+0.35%)
     
  • CAD/USD

    0.8119
    +0.0028 (+0.34%)
     
  • CRUDE OIL

    84.25
    +1.29 (+1.55%)
     
  • BTC-CAD

    81,862.85
    +2,727.39 (+3.45%)
     
  • CMC Crypto 200

    1,550.80
    +70.00 (+4.73%)
     
  • GOLD FUTURES

    1,785.20
    +14.70 (+0.83%)
     
  • RUSSELL 2000

    2,287.73
    +11.81 (+0.52%)
     
  • 10-Yr Bond

    1.6360
    +0.0010 (+0.06%)
     
  • NASDAQ

    15,111.46
    -17.63 (-0.12%)
     
  • VOLATILITY

    15.62
    -0.08 (-0.51%)
     
  • FTSE

    7,223.10
    +5.57 (+0.08%)
     
  • NIKKEI 225

    29,255.55
    +40.03 (+0.14%)
     
  • CAD/EUR

    0.6965
    +0.0014 (+0.20%)
     

Should You Think About Buying Science Group plc (LON:SAG) Now?

  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Science Group plc (LON:SAG), might not be a large cap stock, but it received a lot of attention from a substantial price increase on the AIM over the last few months. Less-covered, small caps tend to present more of an opportunity for mispricing due to the lack of information available to the public, which can be a good thing. So, could the stock still be trading at a low price relative to its actual value? Let’s take a look at Science Group’s outlook and value based on the most recent financial data to see if the opportunity still exists.

Check out our latest analysis for Science Group

What is Science Group worth?

Good news, investors! Science Group is still a bargain right now according to my price multiple model, which compares the company's price-to-earnings ratio to the industry average. In this instance, I’ve used the price-to-earnings (PE) ratio given that there is not enough information to reliably forecast the stock’s cash flows. I find that Science Group’s ratio of 24.25x is below its peer average of 36.24x, which indicates the stock is trading at a lower price compared to the Professional Services industry. Another thing to keep in mind is that Science Group’s share price is quite stable relative to the rest of the market, as indicated by its low beta. This means that if you believe the current share price should move towards its industry peers, a low beta could suggest it is not likely to reach that level anytime soon, and once it’s there, it may be hard to fall back down into an attractive buying range again.

What does the future of Science Group look like?

earnings-and-revenue-growth
earnings-and-revenue-growth

Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Although value investors would argue that it’s the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. Though in the case of Science Group, it is expected to deliver a negative earnings growth of -19%, which doesn’t help build up its investment thesis. It appears that risk of future uncertainty is high, at least in the near term.

What this means for you:

Are you a shareholder? Although SAG is currently trading below the industry PE ratio, the negative profit outlook does bring on some uncertainty, which equates to higher risk. Consider whether you want to increase your portfolio exposure to SAG, or whether diversifying into another stock may be a better move for your total risk and return.

Are you a potential investor? If you’ve been keeping tabs on SAG for some time, but hesitant on making the leap, I recommend you dig deeper into the stock. Given its current price multiple, now is a great time to make a decision. But keep in mind the risks that come with negative growth prospects in the future.

If you want to dive deeper into Science Group, you'd also look into what risks it is currently facing. To help with this, we've discovered 3 warning signs (1 is significant!) that you ought to be aware of before buying any shares in Science Group.

If you are no longer interested in Science Group, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting